Talk Therapy May Reduce Back Pain (CME/CE)
Posted by: SomaNews on: 28 Feb, 2010
Talk Therapy May Reduce Back Pain (CME/CE)
Group cognitive behavioral therapy may help patients with chronic or acute low-back pain, British researchers say.
Posted by: SomaNews on: 28 Feb, 2010
Talk Therapy May Reduce Back Pain (CME/CE)
Group cognitive behavioral therapy may help patients with chronic or acute low-back pain, British researchers say.
Posted by: SomaNews on: 28 Feb, 2010
Stents as Good as Surgery at Preventing Stroke
A less invasive approach for clearing clogged neck arteries proved just as effective and safe as surgical treatment for preventing strokes in high-risk patients, according to largest comparison of the two procedures to date.
Posted by: SomaNews on: 28 Feb, 2010
Salmonella Found in Crushed Red Pepper
Two wholesale lots of crushed red pepper linked to the ongoing national salmonella outbreak have been recalled — and the FDA is looking at whether to recall retail products.
Posted by: SomaNews on: 28 Feb, 2010
Gestational Diabetes Underdiagnosed
In response to research confirming that even small elevations in blood sugar during pregnancy can lead to sick babies, an international panel of experts is recommending sweeping changes in how gestational diabetes is diagnosed.
Posted by: SomaNews on: 28 Feb, 2010
Blacks less likely to know they have atrial fibrillation or about use of warfarin
A large nationwide study that includes neurologists from Mayo Clinic has found that blacks are substantially less likely than whites to know that they have atrial fibrillation or to use warfarin, the most common treatment for the condition. Atrial fibrillation, an abnormal [...]
Posted by: SomaNews on: 28 Feb, 2010
Single submission of orphan drug designation annual report for both FDA and EMA
In recognition of World Rare Disease Day, the U.S. Food and Drug Administration and the European Medicines Agency (EMA) today announced a more streamlined process to help regulators better identify and share information throughout the development process of orphan drug and biologic products, [...]
Posted by: SomaNews on: 28 Feb, 2010
Canada’s pharmaceutical products industry stands out strong during recession
Canada’s pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada’s Canadian Industrial Profile Service – chemicals, plastic and rubber products, non-metallic mineral products, and [...]
Posted by: SomaNews on: 28 Feb, 2010
Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares
Midlothian Laboratories, a division of Hi-Tech Pharmacal Co., Inc., as part of its continuing humanitarian relief efforts, recently donated more than $3 million worth of essential vitamins and nutritional supplements to AmeriCares for people in the developing world living in extreme poverty and [...]
Posted by: SomaNews on: 28 Feb, 2010
Shire receives marketing approval from FDA for VPRIV
Shire plc, the global specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients.
Posted by: SomaNews on: 28 Feb, 2010
Dabigatran as effective as warfarin in preventing subsequent strokes among atrial fibrillation patients
The drug dabigatran was as effective as the currently recommended drug – warfarin – in preventing a subsequent stroke among people with atrial fibrillation and prior stroke or transient ischemic attack – and it did so with less bleeding according to late-breaking science [...]
Recent Comments